Actively Recruiting
Interest of Urinary Oxygen Partial Pressure (PO2u) in Predicting the Onset or Recovery of Acute Renal Failure During Shock States - OXYpi Study
Led by University Hospital, Angers · Updated on 2025-11-20
55
Participants Needed
2
Research Sites
195 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Shock state is defined as an acute, life-threatening, circulatory failure with impaired tissue oxygenation (or tissue hypoxia). The cause of the shock state can be septic, anaphylactic, hypovolemic or cardiogenic. Its management is based on etiological treatment and replacement of organ failures. Acute kidney injury (AKI) may be lead by renal hypoxia. Acute kidney injury is frequent in patients admitted to intensive care unit (ICU) and associated with an increased mortality. Serum creatinine is the reference biological marker in the diagnosis of Acute kidney injury. However, its use is limited by a delayed increase in plasma creatinine level in relation to the causal renal agression, at a time when renal tissue damage may already be established. Thus, the identification of a biological marker making it possible to estimate renal hypoxia continuously during a shock could allow us to identify early a situation at risk of evolving into Acute kidney injury. The renal medulla is vulnerable to tissue hypoxia with a risk of acute tubular necrosis. As in situ measurement of mPO2 is not possible in current practice in humans, several studies have shown a positive correlation between variations in mPO2/uPO2 and occurence of Acute kidney injury. In humans, studies have shown a significant association between the reduction in uPO2 in cardiac surgeries and the occurrence of postoperative Acute kidney injury. The aim of the study is to describe the association between uPO2 values and the onset of Acute kidney injury and/or the ocurrence of early recovery of renal function after Acute kidney injury. Any patient in shock (group A) or without shock and requiring urinary catheterization as part of treatment (group B) admitted to the Medical-Intensive Care Unit of Angers University Hospital is eligible for inclusion. After inclusion, a continuous uPO2 measuring probe is introduced with the placement of the urinary probe. uPO2 is collected continuously for the first 5 days of admission or until discharge from intensive care or removal of the urinary catheter. uPO2 is also measured by a gasometry on a urine sample on a multi-daily basis. Serum creatinine is collected every 12 hours (twice a day) and diuresis every two hours for 5 days.
CONDITIONS
Official Title
Interest of Urinary Oxygen Partial Pressure (PO2u) in Predicting the Onset or Recovery of Acute Renal Failure During Shock States - OXYpi Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient admitted to Intensive Care Unit with shock needing vascular filling and/or catecholamines (Group A)
- Age 18 years or older
- Affiliated or beneficiary of a social security scheme
- Consent given by patient, relative, or emergency inclusion procedure
- Patient admitted to Intensive Care Unit without shock but requiring urinary catheterization (Group B)
- Age 18 years or older
- Affiliated or beneficiary of a social security scheme
- Consent given by patient, relative, or emergency inclusion procedure
You will not qualify if you...
- Preexisting chronic kidney disease (GFR less than 60 mL/min/1.73 m2)
- Chronic dialysis or kidney transplant
- Anuria
- Indication for renal replacement therapy (life-threatening hyperkaliemia, severe metabolic acidosis with pH less than 7.15, uremia greater than 40 mmol/L, pulmonary edema resistant to diuretics)
- Patient requiring extracorporeal life support (ECLS)
- Pregnant, breastfeeding, or parturient woman
- Patient deprived of liberty by judicial or administrative decision
- Patient under psychiatric care
- Patient under legal protection measures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital of Angers
Angers, France, 49933
Actively Recruiting
2
Bicêtre Hospital
Le Kremlin-Bicêtre, France
Not Yet Recruiting
Research Team
N
Nicolas FAGE, PhD
CONTACT
D
DRCI CHU Angers Promotion Internea
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here